Infarction-nephrectomy for metastatic renal carcinoma : Southwest oncology group study
dc.contributor.author | Gottesman, James E. | en_US |
dc.contributor.author | Crawford, E. David | en_US |
dc.contributor.author | Grossman, H. Barton | en_US |
dc.contributor.author | Scardino, Peter L. | en_US |
dc.contributor.author | McCracken, Joseph D. | en_US |
dc.date.accessioned | 2006-04-07T19:08:42Z | |
dc.date.available | 2006-04-07T19:08:42Z | |
dc.date.issued | 1985-03 | en_US |
dc.identifier.citation | Gottesman, James E., Crawford, E. David, Grossman, H. Barton, Scardino, Peter, McCracken, Joseph D. (1985/03)."Infarction-nephrectomy for metastatic renal carcinoma : Southwest oncology group study." Urology 25(3): 248-250. <http://hdl.handle.net/2027.42/25748> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6VJW-4BTY9FM-5G/2/31f3ae6a35336c9c60b39e81d8614590 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/25748 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=3156442&dopt=citation | en_US |
dc.description.abstract | Thirty patients with metastatic renal cell cancer were treated by renal infarction, followed by delayed nephrectomy. All cases were collected over an eighteen-month period, with a minimum follow-up of one year. There were no complete remissions and only one partial remission, which lasted twenty-one months before progression of disease. Three patients had stable disease for at least six months, but eventually all patients showed evidence of progression. After tumor progression was documented patients were treated with intramuscular medroxyprogesterone acetate (Depo-Provera) 800 mg per week. No patient responded to this therapy. Overall, a 28 per cent one-year survival and a seven-month median survival were realized, which is similar to other series in which no therapy or palliative nephrectomy was performed. We conclude that infarction and nephrectomy is not an effective modality in the treatment of metastatic renal cell carcinoma. In addition, medroxyprogesterone was not shown to be significantly active against renal cancer in this study. | en_US |
dc.format.extent | 319009 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Infarction-nephrectomy for metastatic renal carcinoma : Southwest oncology group study | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of New Mexico, Los Cruces, New Mexico, Mexico: University of Michigan Medical Center, Ann Arbor, Michigan, USA: Baylor College of Medicine, Houston, USA: Brooke Army Medical Center, San Antonio, Texas, USA: Seattle Tumor Institute of Swedish Hospital Medical Center, Seattle, Washington, USA | en_US |
dc.contributor.affiliationum | University of New Mexico, Los Cruces, New Mexico, Mexico: University of Michigan Medical Center, Ann Arbor, Michigan, USA: Baylor College of Medicine, Houston, USA: Brooke Army Medical Center, San Antonio, Texas, USA: Seattle Tumor Institute of Swedish Hospital Medical Center, Seattle, Washington, USA | en_US |
dc.contributor.affiliationum | University of New Mexico, Los Cruces, New Mexico, Mexico: University of Michigan Medical Center, Ann Arbor, Michigan, USA: Baylor College of Medicine, Houston, USA: Brooke Army Medical Center, San Antonio, Texas, USA: Seattle Tumor Institute of Swedish Hospital Medical Center, Seattle, Washington, USA | en_US |
dc.contributor.affiliationum | University of New Mexico, Los Cruces, New Mexico, Mexico: University of Michigan Medical Center, Ann Arbor, Michigan, USA: Baylor College of Medicine, Houston, USA: Brooke Army Medical Center, San Antonio, Texas, USA: Seattle Tumor Institute of Swedish Hospital Medical Center, Seattle, Washington, USA | en_US |
dc.contributor.affiliationum | University of New Mexico, Los Cruces, New Mexico, Mexico: University of Michigan Medical Center, Ann Arbor, Michigan, USA: Baylor College of Medicine, Houston, USA: Brooke Army Medical Center, San Antonio, Texas, USA: Seattle Tumor Institute of Swedish Hospital Medical Center, Seattle, Washington, USA | en_US |
dc.identifier.pmid | 3156442 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/25748/1/0000308.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0090-4295(85)90321-8 | en_US |
dc.identifier.source | Urology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.